KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Prepaid Assets (2016 - 2025)

Fulgent Genetics' Prepaid Assets history spans 9 years, with the latest figure at $36.5 million for Q3 2025.

  • For Q3 2025, Prepaid Assets changed N/A year-over-year to $36.5 million; the TTM value through Sep 2025 reached $36.5 million, changed N/A, while the annual FY2024 figure was $23.0 million, 81.63% up from the prior year.
  • Prepaid Assets for Q3 2025 was $36.5 million at Fulgent Genetics, up from $5.3 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $36.5 million in Q3 2025 and bottomed at $1.7 million in Q4 2021.
  • The 5-year median for Prepaid Assets is $9.4 million (2022), against an average of $12.8 million.
  • The largest annual shift saw Prepaid Assets surged 12157.14% in 2021 before it crashed 43.07% in 2025.
  • A 5-year view of Prepaid Assets shows it stood at $1.7 million in 2021, then skyrocketed by 799.42% to $15.4 million in 2022, then decreased by 17.88% to $12.7 million in 2023, then skyrocketed by 81.63% to $23.0 million in 2024, then surged by 58.45% to $36.5 million in 2025.
  • Per Business Quant, the three most recent readings for FLGT's Prepaid Assets are $36.5 million (Q3 2025), $5.3 million (Q2 2025), and $23.0 million (Q4 2024).